Sio Gene Therapies

About:

Sio Gene Therapies is a clinical-stage biopharmaceutical company.

Website: https://siogtx.com/

Twitter/X: siogtx

Top Investors: Hercules Capital

Description:

Sio Gene Therapies, formerly known as Axovant, is a clinical-stage company with a singular focus on pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases, including GM1 gangliosidosis, Tay-Sachs/Sandhoff disease, and Parkinson’s disease. Sio is leveraging its foundational scientific expertise built on decades of research, extensive collaborations with leading gene therapy institutes, and a flexible vector platform to liberate patients with debilitating diseases through the transformational power of gene therapies.